- Home
- GSRT vs ZBIO Comparison
GSRT vs ZBIO Comparison
Compare GSRT & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSRT
- ZBIO
- Stock Information
- Founded
- GSRT 2023
- ZBIO 2019
- Country
- GSRT United States
- ZBIO United States
- Employees
- GSRT N/A
- ZBIO N/A
- Industry
- GSRT
- ZBIO
- Sector
- GSRT
- ZBIO
- Exchange
- GSRT Nasdaq
- ZBIO NYSE
- Market Cap
- GSRT 292.6M
- ZBIO 268.7M
- IPO Year
- GSRT 2024
- ZBIO 2024
- Fundamental
- Price
- GSRT $10.00
- ZBIO $7.90
- Analyst Decision
- GSRT
- ZBIO Strong Buy
- Analyst Count
- GSRT 0
- ZBIO 6
- Target Price
- GSRT N/A
- ZBIO $31.83
- AVG Volume (30 Days)
- GSRT 3.7K
- ZBIO 130.1K
- Earning Date
- GSRT 01-01-0001
- ZBIO 03-25-2025
- Dividend Yield
- GSRT N/A
- ZBIO N/A
- EPS Growth
- GSRT N/A
- ZBIO N/A
- EPS
- GSRT N/A
- ZBIO N/A
- Revenue
- GSRT N/A
- ZBIO $5,000,000.00
- Revenue This Year
- GSRT N/A
- ZBIO N/A
- Revenue Next Year
- GSRT N/A
- ZBIO N/A
- P/E Ratio
- GSRT N/A
- ZBIO N/A
- Revenue Growth
- GSRT N/A
- ZBIO N/A
- 52 Week Low
- GSRT $9.97
- ZBIO $5.83
- 52 Week High
- GSRT $10.23
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- GSRT N/A
- ZBIO N/A
- Support Level
- GSRT N/A
- ZBIO N/A
- Resistance Level
- GSRT N/A
- ZBIO N/A
- Average True Range (ATR)
- GSRT 0.00
- ZBIO 0.00
- MACD
- GSRT 0.00
- ZBIO 0.00
- Stochastic Oscillator
- GSRT 0.00
- ZBIO 0.00
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.